Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.
read more
Meribel Pharma Solutions has launched with ten manufacturing sites and three drug development services sites, situated across France, Spain and Sweden, following the acquisition of CDMO, Synerlab Group and seven European manufacturing facilities from...
read more
Wednesday, September 02, 2015
Novartis announced that the European Commission has approved Revolade® (eltrombopag) for the treatment of adults with severe aplastic anemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable ...
read more
The Board of the European Fine Chemicals Group (EFCG) announces that the 6th EFCG Annual Dinner will be held on 23rd October 2013 in Frankfurt at The InterContinental Hotel.
read more
The European Medicines Agency has released a draft policy on the publication and access to clinical-trial data for a three-month public consultation. Stakeholders have until 30 September 2013 to send their comments on the draft policy to the Agency.
read more
Wednesday, December 05, 2012
The European Medicines Agency today published a report highlighting the outcomes of the workshop on access to clinical-trial data and transparency which was hosted at the Agency on 22 November 2012.
read more
Friday, December 20, 2013
The European Medicines Agency (EMA) has now reviewed all comments received on its draft policy on publication and access to clinical trial data. While the comments received showed that there is large support for the Agency’s plans to allow access to ...
read more
Friday, November 21, 2014
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue and staff numbers despite ever-increasing international competition. This continues Munich's status as one of the pre-eminent locations for this ...
read more
Tuesday, September 29, 2020
Europital has announced an expansion as it launches new capabilities across project management, clinical monitoring, biostatistics, pharmacovigilance, regulatory affairs and data management, in addition to its existing services of Medical Affairs and...
read more
Evecxia has expanded its previous license agreement with Duke University to include exclusive, world-wide rights to develop and commercialize methods of improving the bioavailability of 5-HTP.
read more
Thursday, September 21, 2023
A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive ...
read more
Friday, September 22, 2023
The drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive ...
read more
In light of the fast-paced healthcare digital revolution, Oxford Global’s 15th Annual Pharmaceutical IT Congress, is bursting with information on best practice, key challenges, opportunities and new tools and systems.
read more
Tuesday, November 07, 2023
Everest Clinical Research, a comprehensive contract research organization (CRO), has announced its acquisition of August Research. Everest, backed by Arlington Capital Partners, a private equity firm based in Washington, D.C. specializing in ...
read more
Monday, December 05, 2022
Founded in 2002, Brightech specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a highly-regarded reputation as a critical partner for some of the world’s largest...
read more